nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—CYP2C19—coronary artery disease	0.241	1	CbGaD
Bupivacaine—CYP2C19—Gemfibrozil—coronary artery disease	0.0307	0.0629	CbGbCtD
Bupivacaine—CYP1A2—Gemfibrozil—coronary artery disease	0.0283	0.0581	CbGbCtD
Bupivacaine—CYP2C19—Clopidogrel—coronary artery disease	0.0266	0.0546	CbGbCtD
Bupivacaine—CYP1A2—Clopidogrel—coronary artery disease	0.0245	0.0504	CbGbCtD
Bupivacaine—CYP2C19—Telmisartan—coronary artery disease	0.0233	0.0477	CbGbCtD
Bupivacaine—CYP3A4—Ticagrelor—coronary artery disease	0.0208	0.0427	CbGbCtD
Bupivacaine—CYP2C19—Timolol—coronary artery disease	0.0187	0.0384	CbGbCtD
Bupivacaine—CYP3A4—Fenofibrate—coronary artery disease	0.0186	0.0381	CbGbCtD
Bupivacaine—CYP2C19—Rosuvastatin—coronary artery disease	0.0171	0.0352	CbGbCtD
Bupivacaine—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.0167	0.0343	CbGbCtD
Bupivacaine—CYP2C19—Simvastatin—coronary artery disease	0.0159	0.0327	CbGbCtD
Bupivacaine—CYP2C19—Lovastatin—coronary artery disease	0.0156	0.032	CbGbCtD
Bupivacaine—CYP2D6—Niacin—coronary artery disease	0.0153	0.0314	CbGbCtD
Bupivacaine—CYP3A4—Gemfibrozil—coronary artery disease	0.0148	0.0304	CbGbCtD
Bupivacaine—CYP2D6—Timolol—coronary artery disease	0.0142	0.0292	CbGbCtD
Bupivacaine—CYP2C19—Atorvastatin—coronary artery disease	0.0142	0.0291	CbGbCtD
Bupivacaine—CYP2C19—Losartan—coronary artery disease	0.013	0.0267	CbGbCtD
Bupivacaine—CYP3A4—Clopidogrel—coronary artery disease	0.0129	0.0264	CbGbCtD
Bupivacaine—CYP2D6—Captopril—coronary artery disease	0.0125	0.0257	CbGbCtD
Bupivacaine—CYP2D6—Simvastatin—coronary artery disease	0.0121	0.0249	CbGbCtD
Bupivacaine—CYP1A2—Losartan—coronary artery disease	0.012	0.0246	CbGbCtD
Bupivacaine—CYP3A4—Eplerenone—coronary artery disease	0.012	0.0245	CbGbCtD
Bupivacaine—CYP2D6—Pravastatin—coronary artery disease	0.0119	0.0243	CbGbCtD
Bupivacaine—CYP2D6—Lovastatin—coronary artery disease	0.0119	0.0243	CbGbCtD
Bupivacaine—CYP2D6—Atorvastatin—coronary artery disease	0.0108	0.0222	CbGbCtD
Bupivacaine—CYP3A4—Enalapril—coronary artery disease	0.0107	0.0219	CbGbCtD
Bupivacaine—CYP3A4—Rosuvastatin—coronary artery disease	0.00829	0.017	CbGbCtD
Bupivacaine—CYP3A4—Ezetimibe—coronary artery disease	0.00829	0.017	CbGbCtD
Bupivacaine—CYP3A4—Simvastatin—coronary artery disease	0.0077	0.0158	CbGbCtD
Bupivacaine—CYP3A4—Pravastatin—coronary artery disease	0.00754	0.0155	CbGbCtD
Bupivacaine—CYP3A4—Lovastatin—coronary artery disease	0.00754	0.0155	CbGbCtD
Bupivacaine—CYP3A4—Atorvastatin—coronary artery disease	0.00687	0.0141	CbGbCtD
Bupivacaine—CYP3A4—Losartan—coronary artery disease	0.00628	0.0129	CbGbCtD
Bupivacaine—Loss of consciousness—Timolol—coronary artery disease	7.63e-05	0.000383	CcSEcCtD
Bupivacaine—Decreased appetite—Furosemide—coronary artery disease	7.62e-05	0.000383	CcSEcCtD
Bupivacaine—Headache—Fenofibrate—coronary artery disease	7.59e-05	0.000381	CcSEcCtD
Bupivacaine—Vision blurred—Lisinopril—coronary artery disease	7.59e-05	0.000381	CcSEcCtD
Bupivacaine—Paraesthesia—Losartan—coronary artery disease	7.59e-05	0.000381	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Captopril—coronary artery disease	7.59e-05	0.000381	CcSEcCtD
Bupivacaine—Urticaria—Telmisartan—coronary artery disease	7.59e-05	0.000381	CcSEcCtD
Bupivacaine—Cough—Timolol—coronary artery disease	7.58e-05	0.000381	CcSEcCtD
Bupivacaine—Vomiting—Clopidogrel—coronary artery disease	7.58e-05	0.000381	CcSEcCtD
Bupivacaine—Diarrhoea—Simvastatin—coronary artery disease	7.58e-05	0.000381	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Furosemide—coronary artery disease	7.57e-05	0.00038	CcSEcCtD
Bupivacaine—Arthralgia—Ramipril—coronary artery disease	7.56e-05	0.00038	CcSEcCtD
Bupivacaine—Tremor—Lisinopril—coronary artery disease	7.55e-05	0.000379	CcSEcCtD
Bupivacaine—Abdominal pain—Telmisartan—coronary artery disease	7.55e-05	0.000379	CcSEcCtD
Bupivacaine—Body temperature increased—Telmisartan—coronary artery disease	7.55e-05	0.000379	CcSEcCtD
Bupivacaine—Dyspnoea—Losartan—coronary artery disease	7.54e-05	0.000379	CcSEcCtD
Bupivacaine—Anxiety—Ramipril—coronary artery disease	7.54e-05	0.000379	CcSEcCtD
Bupivacaine—Vomiting—Lovastatin—coronary artery disease	7.53e-05	0.000378	CcSEcCtD
Bupivacaine—Somnolence—Losartan—coronary artery disease	7.52e-05	0.000378	CcSEcCtD
Bupivacaine—Dizziness—Eplerenone—coronary artery disease	7.51e-05	0.000377	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	7.51e-05	0.000377	CcSEcCtD
Bupivacaine—Asthenia—Valsartan—coronary artery disease	7.5e-05	0.000377	CcSEcCtD
Bupivacaine—Hypertension—Timolol—coronary artery disease	7.5e-05	0.000377	CcSEcCtD
Bupivacaine—Pain—Furosemide—coronary artery disease	7.49e-05	0.000376	CcSEcCtD
Bupivacaine—Constipation—Furosemide—coronary artery disease	7.49e-05	0.000376	CcSEcCtD
Bupivacaine—Hypersensitivity—Niacin—coronary artery disease	7.49e-05	0.000376	CcSEcCtD
Bupivacaine—Asthenia—Olmesartan—coronary artery disease	7.47e-05	0.000375	CcSEcCtD
Bupivacaine—Headache—Clopidogrel—coronary artery disease	7.46e-05	0.000375	CcSEcCtD
Bupivacaine—Anaemia—Lisinopril—coronary artery disease	7.45e-05	0.000374	CcSEcCtD
Bupivacaine—Dyspepsia—Losartan—coronary artery disease	7.44e-05	0.000374	CcSEcCtD
Bupivacaine—Feeling abnormal—Perindopril—coronary artery disease	7.43e-05	0.000373	CcSEcCtD
Bupivacaine—Headache—Lovastatin—coronary artery disease	7.42e-05	0.000373	CcSEcCtD
Bupivacaine—Pruritus—Valsartan—coronary artery disease	7.4e-05	0.000372	CcSEcCtD
Bupivacaine—Arthralgia—Timolol—coronary artery disease	7.39e-05	0.000371	CcSEcCtD
Bupivacaine—Vomiting—Ezetimibe—coronary artery disease	7.38e-05	0.000371	CcSEcCtD
Bupivacaine—Hypersensitivity—Pravastatin—coronary artery disease	7.37e-05	0.00037	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Perindopril—coronary artery disease	7.37e-05	0.00037	CcSEcCtD
Bupivacaine—Anxiety—Timolol—coronary artery disease	7.37e-05	0.00037	CcSEcCtD
Bupivacaine—Angioedema—Lisinopril—coronary artery disease	7.36e-05	0.00037	CcSEcCtD
Bupivacaine—Pruritus—Olmesartan—coronary artery disease	7.36e-05	0.00037	CcSEcCtD
Bupivacaine—Decreased appetite—Losartan—coronary artery disease	7.35e-05	0.000369	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	7.34e-05	0.000369	CcSEcCtD
Bupivacaine—Abdominal pain—Captopril—coronary artery disease	7.34e-05	0.000369	CcSEcCtD
Bupivacaine—Body temperature increased—Captopril—coronary artery disease	7.34e-05	0.000369	CcSEcCtD
Bupivacaine—Dizziness—Simvastatin—coronary artery disease	7.32e-05	0.000368	CcSEcCtD
Bupivacaine—Confusional state—Ramipril—coronary artery disease	7.31e-05	0.000367	CcSEcCtD
Bupivacaine—Asthenia—Niacin—coronary artery disease	7.29e-05	0.000366	CcSEcCtD
Bupivacaine—Headache—Ezetimibe—coronary artery disease	7.27e-05	0.000365	CcSEcCtD
Bupivacaine—Anaphylactic shock—Ramipril—coronary artery disease	7.25e-05	0.000364	CcSEcCtD
Bupivacaine—Oedema—Ramipril—coronary artery disease	7.25e-05	0.000364	CcSEcCtD
Bupivacaine—Constipation—Losartan—coronary artery disease	7.23e-05	0.000363	CcSEcCtD
Bupivacaine—Pain—Losartan—coronary artery disease	7.23e-05	0.000363	CcSEcCtD
Bupivacaine—Syncope—Lisinopril—coronary artery disease	7.23e-05	0.000363	CcSEcCtD
Bupivacaine—Vomiting—Eplerenone—coronary artery disease	7.22e-05	0.000363	CcSEcCtD
Bupivacaine—Feeling abnormal—Furosemide—coronary artery disease	7.22e-05	0.000363	CcSEcCtD
Bupivacaine—Nausea—Fenofibrate—coronary artery disease	7.2e-05	0.000362	CcSEcCtD
Bupivacaine—Pruritus—Niacin—coronary artery disease	7.19e-05	0.000361	CcSEcCtD
Bupivacaine—Asthenia—Pravastatin—coronary artery disease	7.18e-05	0.000361	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Furosemide—coronary artery disease	7.17e-05	0.00036	CcSEcCtD
Bupivacaine—Urticaria—Perindopril—coronary artery disease	7.16e-05	0.00036	CcSEcCtD
Bupivacaine—Hypersensitivity—Trandolapril—coronary artery disease	7.16e-05	0.00036	CcSEcCtD
Bupivacaine—Diarrhoea—Valsartan—coronary artery disease	7.15e-05	0.000359	CcSEcCtD
Bupivacaine—Confusional state—Timolol—coronary artery disease	7.15e-05	0.000359	CcSEcCtD
Bupivacaine—Shock—Ramipril—coronary artery disease	7.13e-05	0.000358	CcSEcCtD
Bupivacaine—Hypersensitivity—Enalapril—coronary artery disease	7.13e-05	0.000358	CcSEcCtD
Bupivacaine—Abdominal pain—Perindopril—coronary artery disease	7.13e-05	0.000358	CcSEcCtD
Bupivacaine—Body temperature increased—Perindopril—coronary artery disease	7.13e-05	0.000358	CcSEcCtD
Bupivacaine—Palpitations—Lisinopril—coronary artery disease	7.12e-05	0.000358	CcSEcCtD
Bupivacaine—Diarrhoea—Olmesartan—coronary artery disease	7.12e-05	0.000358	CcSEcCtD
Bupivacaine—Headache—Eplerenone—coronary artery disease	7.12e-05	0.000358	CcSEcCtD
Bupivacaine—Nervous system disorder—Ramipril—coronary artery disease	7.11e-05	0.000357	CcSEcCtD
Bupivacaine—Anaphylactic shock—Timolol—coronary artery disease	7.09e-05	0.000356	CcSEcCtD
Bupivacaine—Oedema—Timolol—coronary artery disease	7.09e-05	0.000356	CcSEcCtD
Bupivacaine—Pruritus—Pravastatin—coronary artery disease	7.08e-05	0.000356	CcSEcCtD
Bupivacaine—Loss of consciousness—Lisinopril—coronary artery disease	7.08e-05	0.000356	CcSEcCtD
Bupivacaine—Nausea—Clopidogrel—coronary artery disease	7.08e-05	0.000356	CcSEcCtD
Bupivacaine—Tachycardia—Ramipril—coronary artery disease	7.08e-05	0.000355	CcSEcCtD
Bupivacaine—Skin disorder—Ramipril—coronary artery disease	7.04e-05	0.000354	CcSEcCtD
Bupivacaine—Infection—Timolol—coronary artery disease	7.04e-05	0.000354	CcSEcCtD
Bupivacaine—Vomiting—Simvastatin—coronary artery disease	7.04e-05	0.000354	CcSEcCtD
Bupivacaine—Hypersensitivity—Telmisartan—coronary artery disease	7.04e-05	0.000353	CcSEcCtD
Bupivacaine—Cough—Lisinopril—coronary artery disease	7.03e-05	0.000353	CcSEcCtD
Bupivacaine—Nausea—Lovastatin—coronary artery disease	7.03e-05	0.000353	CcSEcCtD
Bupivacaine—Hyperhidrosis—Ramipril—coronary artery disease	7.01e-05	0.000352	CcSEcCtD
Bupivacaine—Asthenia—Trandolapril—coronary artery disease	6.97e-05	0.00035	CcSEcCtD
Bupivacaine—Shock—Timolol—coronary artery disease	6.97e-05	0.00035	CcSEcCtD
Bupivacaine—Feeling abnormal—Losartan—coronary artery disease	6.97e-05	0.00035	CcSEcCtD
Bupivacaine—Urticaria—Furosemide—coronary artery disease	6.96e-05	0.00035	CcSEcCtD
Bupivacaine—Diarrhoea—Niacin—coronary artery disease	6.96e-05	0.000349	CcSEcCtD
Bupivacaine—Nervous system disorder—Timolol—coronary artery disease	6.95e-05	0.000349	CcSEcCtD
Bupivacaine—Asthenia—Enalapril—coronary artery disease	6.95e-05	0.000349	CcSEcCtD
Bupivacaine—Headache—Simvastatin—coronary artery disease	6.94e-05	0.000348	CcSEcCtD
Bupivacaine—Abdominal pain—Furosemide—coronary artery disease	6.93e-05	0.000348	CcSEcCtD
Bupivacaine—Body temperature increased—Furosemide—coronary artery disease	6.93e-05	0.000348	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Losartan—coronary artery disease	6.91e-05	0.000347	CcSEcCtD
Bupivacaine—Dizziness—Valsartan—coronary artery disease	6.91e-05	0.000347	CcSEcCtD
Bupivacaine—Nausea—Ezetimibe—coronary artery disease	6.9e-05	0.000346	CcSEcCtD
Bupivacaine—Skin disorder—Timolol—coronary artery disease	6.89e-05	0.000346	CcSEcCtD
Bupivacaine—Dizziness—Olmesartan—coronary artery disease	6.88e-05	0.000346	CcSEcCtD
Bupivacaine—Pruritus—Trandolapril—coronary artery disease	6.88e-05	0.000345	CcSEcCtD
Bupivacaine—Arthralgia—Lisinopril—coronary artery disease	6.86e-05	0.000345	CcSEcCtD
Bupivacaine—Hyperhidrosis—Timolol—coronary artery disease	6.85e-05	0.000344	CcSEcCtD
Bupivacaine—Asthenia—Telmisartan—coronary artery disease	6.85e-05	0.000344	CcSEcCtD
Bupivacaine—Pruritus—Enalapril—coronary artery disease	6.85e-05	0.000344	CcSEcCtD
Bupivacaine—Diarrhoea—Pravastatin—coronary artery disease	6.85e-05	0.000344	CcSEcCtD
Bupivacaine—Anxiety—Lisinopril—coronary artery disease	6.84e-05	0.000343	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	6.81e-05	0.000342	CcSEcCtD
Bupivacaine—Hypotension—Ramipril—coronary artery disease	6.78e-05	0.00034	CcSEcCtD
Bupivacaine—Pruritus—Telmisartan—coronary artery disease	6.76e-05	0.000339	CcSEcCtD
Bupivacaine—Nausea—Eplerenone—coronary artery disease	6.75e-05	0.000339	CcSEcCtD
Bupivacaine—Dizziness—Niacin—coronary artery disease	6.72e-05	0.000338	CcSEcCtD
Bupivacaine—Urticaria—Losartan—coronary artery disease	6.72e-05	0.000337	CcSEcCtD
Bupivacaine—Body temperature increased—Losartan—coronary artery disease	6.68e-05	0.000336	CcSEcCtD
Bupivacaine—Abdominal pain—Losartan—coronary artery disease	6.68e-05	0.000336	CcSEcCtD
Bupivacaine—Asthenia—Captopril—coronary artery disease	6.66e-05	0.000335	CcSEcCtD
Bupivacaine—Diarrhoea—Trandolapril—coronary artery disease	6.65e-05	0.000334	CcSEcCtD
Bupivacaine—Vomiting—Valsartan—coronary artery disease	6.65e-05	0.000334	CcSEcCtD
Bupivacaine—Confusional state—Lisinopril—coronary artery disease	6.63e-05	0.000333	CcSEcCtD
Bupivacaine—Diarrhoea—Enalapril—coronary artery disease	6.62e-05	0.000333	CcSEcCtD
Bupivacaine—Hypotension—Timolol—coronary artery disease	6.62e-05	0.000333	CcSEcCtD
Bupivacaine—Dizziness—Pravastatin—coronary artery disease	6.62e-05	0.000333	CcSEcCtD
Bupivacaine—Vomiting—Olmesartan—coronary artery disease	6.62e-05	0.000332	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Ramipril—coronary artery disease	6.61e-05	0.000332	CcSEcCtD
Bupivacaine—Nausea—Simvastatin—coronary artery disease	6.58e-05	0.00033	CcSEcCtD
Bupivacaine—Anaphylactic shock—Lisinopril—coronary artery disease	6.58e-05	0.00033	CcSEcCtD
Bupivacaine—Oedema—Lisinopril—coronary artery disease	6.58e-05	0.00033	CcSEcCtD
Bupivacaine—Pruritus—Captopril—coronary artery disease	6.57e-05	0.00033	CcSEcCtD
Bupivacaine—Insomnia—Ramipril—coronary artery disease	6.56e-05	0.000329	CcSEcCtD
Bupivacaine—Headache—Valsartan—coronary artery disease	6.55e-05	0.000329	CcSEcCtD
Bupivacaine—Diarrhoea—Telmisartan—coronary artery disease	6.53e-05	0.000328	CcSEcCtD
Bupivacaine—Infection—Lisinopril—coronary artery disease	6.53e-05	0.000328	CcSEcCtD
Bupivacaine—Headache—Olmesartan—coronary artery disease	6.52e-05	0.000327	CcSEcCtD
Bupivacaine—Paraesthesia—Ramipril—coronary artery disease	6.51e-05	0.000327	CcSEcCtD
Bupivacaine—Shock—Lisinopril—coronary artery disease	6.47e-05	0.000325	CcSEcCtD
Bupivacaine—Asthenia—Perindopril—coronary artery disease	6.47e-05	0.000325	CcSEcCtD
Bupivacaine—Dyspnoea—Ramipril—coronary artery disease	6.46e-05	0.000325	CcSEcCtD
Bupivacaine—Vomiting—Niacin—coronary artery disease	6.46e-05	0.000325	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Timolol—coronary artery disease	6.46e-05	0.000324	CcSEcCtD
Bupivacaine—Hypersensitivity—Furosemide—coronary artery disease	6.46e-05	0.000324	CcSEcCtD
Bupivacaine—Somnolence—Ramipril—coronary artery disease	6.45e-05	0.000324	CcSEcCtD
Bupivacaine—Dizziness—Trandolapril—coronary artery disease	6.43e-05	0.000323	CcSEcCtD
Bupivacaine—Tachycardia—Lisinopril—coronary artery disease	6.42e-05	0.000322	CcSEcCtD
Bupivacaine—Insomnia—Timolol—coronary artery disease	6.41e-05	0.000322	CcSEcCtD
Bupivacaine—Dizziness—Enalapril—coronary artery disease	6.4e-05	0.000322	CcSEcCtD
Bupivacaine—Skin disorder—Lisinopril—coronary artery disease	6.39e-05	0.000321	CcSEcCtD
Bupivacaine—Dyspepsia—Ramipril—coronary artery disease	6.38e-05	0.000321	CcSEcCtD
Bupivacaine—Pruritus—Perindopril—coronary artery disease	6.38e-05	0.00032	CcSEcCtD
Bupivacaine—Headache—Niacin—coronary artery disease	6.37e-05	0.00032	CcSEcCtD
Bupivacaine—Paraesthesia—Timolol—coronary artery disease	6.37e-05	0.00032	CcSEcCtD
Bupivacaine—Vomiting—Pravastatin—coronary artery disease	6.36e-05	0.00032	CcSEcCtD
Bupivacaine—Hyperhidrosis—Lisinopril—coronary artery disease	6.36e-05	0.000319	CcSEcCtD
Bupivacaine—Diarrhoea—Captopril—coronary artery disease	6.35e-05	0.000319	CcSEcCtD
Bupivacaine—Dyspnoea—Timolol—coronary artery disease	6.32e-05	0.000317	CcSEcCtD
Bupivacaine—Dizziness—Telmisartan—coronary artery disease	6.31e-05	0.000317	CcSEcCtD
Bupivacaine—Decreased appetite—Ramipril—coronary artery disease	6.3e-05	0.000317	CcSEcCtD
Bupivacaine—Somnolence—Timolol—coronary artery disease	6.3e-05	0.000317	CcSEcCtD
Bupivacaine—Asthenia—Furosemide—coronary artery disease	6.29e-05	0.000316	CcSEcCtD
Bupivacaine—Headache—Pravastatin—coronary artery disease	6.27e-05	0.000315	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Ramipril—coronary artery disease	6.26e-05	0.000314	CcSEcCtD
Bupivacaine—Dyspepsia—Timolol—coronary artery disease	6.24e-05	0.000313	CcSEcCtD
Bupivacaine—Hypersensitivity—Losartan—coronary artery disease	6.23e-05	0.000313	CcSEcCtD
Bupivacaine—Nausea—Valsartan—coronary artery disease	6.21e-05	0.000312	CcSEcCtD
Bupivacaine—Pruritus—Furosemide—coronary artery disease	6.2e-05	0.000311	CcSEcCtD
Bupivacaine—Constipation—Ramipril—coronary artery disease	6.2e-05	0.000311	CcSEcCtD
Bupivacaine—Nausea—Olmesartan—coronary artery disease	6.18e-05	0.00031	CcSEcCtD
Bupivacaine—Vomiting—Trandolapril—coronary artery disease	6.18e-05	0.00031	CcSEcCtD
Bupivacaine—Diarrhoea—Perindopril—coronary artery disease	6.17e-05	0.00031	CcSEcCtD
Bupivacaine—Decreased appetite—Timolol—coronary artery disease	6.16e-05	0.00031	CcSEcCtD
Bupivacaine—Vomiting—Enalapril—coronary artery disease	6.16e-05	0.000309	CcSEcCtD
Bupivacaine—Hypotension—Lisinopril—coronary artery disease	6.14e-05	0.000309	CcSEcCtD
Bupivacaine—Dizziness—Captopril—coronary artery disease	6.14e-05	0.000308	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Timolol—coronary artery disease	6.12e-05	0.000307	CcSEcCtD
Bupivacaine—Headache—Trandolapril—coronary artery disease	6.09e-05	0.000306	CcSEcCtD
Bupivacaine—Vomiting—Telmisartan—coronary artery disease	6.07e-05	0.000305	CcSEcCtD
Bupivacaine—Asthenia—Losartan—coronary artery disease	6.07e-05	0.000305	CcSEcCtD
Bupivacaine—Headache—Enalapril—coronary artery disease	6.07e-05	0.000305	CcSEcCtD
Bupivacaine—Pain—Timolol—coronary artery disease	6.06e-05	0.000305	CcSEcCtD
Bupivacaine—Nausea—Niacin—coronary artery disease	6.04e-05	0.000303	CcSEcCtD
Bupivacaine—Diarrhoea—Furosemide—coronary artery disease	6e-05	0.000301	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	5.99e-05	0.000301	CcSEcCtD
Bupivacaine—Pruritus—Losartan—coronary artery disease	5.98e-05	0.000301	CcSEcCtD
Bupivacaine—Headache—Telmisartan—coronary artery disease	5.98e-05	0.000301	CcSEcCtD
Bupivacaine—Feeling abnormal—Ramipril—coronary artery disease	5.98e-05	0.0003	CcSEcCtD
Bupivacaine—Dizziness—Perindopril—coronary artery disease	5.96e-05	0.000299	CcSEcCtD
Bupivacaine—Insomnia—Lisinopril—coronary artery disease	5.95e-05	0.000299	CcSEcCtD
Bupivacaine—Nausea—Pravastatin—coronary artery disease	5.95e-05	0.000299	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Ramipril—coronary artery disease	5.93e-05	0.000298	CcSEcCtD
Bupivacaine—Paraesthesia—Lisinopril—coronary artery disease	5.9e-05	0.000297	CcSEcCtD
Bupivacaine—Vomiting—Captopril—coronary artery disease	5.9e-05	0.000297	CcSEcCtD
Bupivacaine—Dyspnoea—Lisinopril—coronary artery disease	5.86e-05	0.000295	CcSEcCtD
Bupivacaine—Somnolence—Lisinopril—coronary artery disease	5.85e-05	0.000294	CcSEcCtD
Bupivacaine—Feeling abnormal—Timolol—coronary artery disease	5.84e-05	0.000293	CcSEcCtD
Bupivacaine—Headache—Captopril—coronary artery disease	5.82e-05	0.000292	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Timolol—coronary artery disease	5.8e-05	0.000291	CcSEcCtD
Bupivacaine—Dizziness—Furosemide—coronary artery disease	5.8e-05	0.000291	CcSEcCtD
Bupivacaine—Dyspepsia—Lisinopril—coronary artery disease	5.79e-05	0.000291	CcSEcCtD
Bupivacaine—Diarrhoea—Losartan—coronary artery disease	5.79e-05	0.000291	CcSEcCtD
Bupivacaine—Nausea—Trandolapril—coronary artery disease	5.77e-05	0.00029	CcSEcCtD
Bupivacaine—Urticaria—Ramipril—coronary artery disease	5.76e-05	0.000289	CcSEcCtD
Bupivacaine—Nausea—Enalapril—coronary artery disease	5.75e-05	0.000289	CcSEcCtD
Bupivacaine—Vomiting—Perindopril—coronary artery disease	5.73e-05	0.000288	CcSEcCtD
Bupivacaine—Abdominal pain—Ramipril—coronary artery disease	5.73e-05	0.000288	CcSEcCtD
Bupivacaine—Body temperature increased—Ramipril—coronary artery disease	5.73e-05	0.000288	CcSEcCtD
Bupivacaine—Decreased appetite—Lisinopril—coronary artery disease	5.72e-05	0.000287	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.68e-05	0.000285	CcSEcCtD
Bupivacaine—Nausea—Telmisartan—coronary artery disease	5.67e-05	0.000285	CcSEcCtD
Bupivacaine—Headache—Perindopril—coronary artery disease	5.65e-05	0.000284	CcSEcCtD
Bupivacaine—Urticaria—Timolol—coronary artery disease	5.63e-05	0.000283	CcSEcCtD
Bupivacaine—Pain—Lisinopril—coronary artery disease	5.62e-05	0.000282	CcSEcCtD
Bupivacaine—Constipation—Lisinopril—coronary artery disease	5.62e-05	0.000282	CcSEcCtD
Bupivacaine—Body temperature increased—Timolol—coronary artery disease	5.6e-05	0.000281	CcSEcCtD
Bupivacaine—Abdominal pain—Timolol—coronary artery disease	5.6e-05	0.000281	CcSEcCtD
Bupivacaine—Dizziness—Losartan—coronary artery disease	5.59e-05	0.000281	CcSEcCtD
Bupivacaine—Vomiting—Furosemide—coronary artery disease	5.57e-05	0.00028	CcSEcCtD
Bupivacaine—Nausea—Captopril—coronary artery disease	5.52e-05	0.000277	CcSEcCtD
Bupivacaine—Headache—Furosemide—coronary artery disease	5.49e-05	0.000276	CcSEcCtD
Bupivacaine—Feeling abnormal—Lisinopril—coronary artery disease	5.42e-05	0.000272	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Lisinopril—coronary artery disease	5.38e-05	0.00027	CcSEcCtD
Bupivacaine—Vomiting—Losartan—coronary artery disease	5.38e-05	0.00027	CcSEcCtD
Bupivacaine—Nausea—Perindopril—coronary artery disease	5.36e-05	0.000269	CcSEcCtD
Bupivacaine—Hypersensitivity—Ramipril—coronary artery disease	5.34e-05	0.000268	CcSEcCtD
Bupivacaine—Headache—Losartan—coronary artery disease	5.3e-05	0.000266	CcSEcCtD
Bupivacaine—Urticaria—Lisinopril—coronary artery disease	5.22e-05	0.000262	CcSEcCtD
Bupivacaine—Hypersensitivity—Timolol—coronary artery disease	5.22e-05	0.000262	CcSEcCtD
Bupivacaine—Nausea—Furosemide—coronary artery disease	5.21e-05	0.000262	CcSEcCtD
Bupivacaine—Asthenia—Ramipril—coronary artery disease	5.2e-05	0.000261	CcSEcCtD
Bupivacaine—Body temperature increased—Lisinopril—coronary artery disease	5.2e-05	0.000261	CcSEcCtD
Bupivacaine—Abdominal pain—Lisinopril—coronary artery disease	5.2e-05	0.000261	CcSEcCtD
Bupivacaine—Pruritus—Ramipril—coronary artery disease	5.13e-05	0.000258	CcSEcCtD
Bupivacaine—Asthenia—Timolol—coronary artery disease	5.09e-05	0.000255	CcSEcCtD
Bupivacaine—Nausea—Losartan—coronary artery disease	5.02e-05	0.000252	CcSEcCtD
Bupivacaine—Pruritus—Timolol—coronary artery disease	5.02e-05	0.000252	CcSEcCtD
Bupivacaine—Diarrhoea—Ramipril—coronary artery disease	4.96e-05	0.000249	CcSEcCtD
Bupivacaine—Diarrhoea—Timolol—coronary artery disease	4.85e-05	0.000244	CcSEcCtD
Bupivacaine—Hypersensitivity—Lisinopril—coronary artery disease	4.84e-05	0.000243	CcSEcCtD
Bupivacaine—Dizziness—Ramipril—coronary artery disease	4.79e-05	0.000241	CcSEcCtD
Bupivacaine—Asthenia—Lisinopril—coronary artery disease	4.72e-05	0.000237	CcSEcCtD
Bupivacaine—Dizziness—Timolol—coronary artery disease	4.69e-05	0.000235	CcSEcCtD
Bupivacaine—Pruritus—Lisinopril—coronary artery disease	4.65e-05	0.000234	CcSEcCtD
Bupivacaine—Vomiting—Ramipril—coronary artery disease	4.61e-05	0.000232	CcSEcCtD
Bupivacaine—Headache—Ramipril—coronary artery disease	4.54e-05	0.000228	CcSEcCtD
Bupivacaine—Vomiting—Timolol—coronary artery disease	4.51e-05	0.000226	CcSEcCtD
Bupivacaine—Diarrhoea—Lisinopril—coronary artery disease	4.5e-05	0.000226	CcSEcCtD
Bupivacaine—Headache—Timolol—coronary artery disease	4.44e-05	0.000223	CcSEcCtD
Bupivacaine—Dizziness—Lisinopril—coronary artery disease	4.35e-05	0.000218	CcSEcCtD
Bupivacaine—Nausea—Ramipril—coronary artery disease	4.31e-05	0.000216	CcSEcCtD
Bupivacaine—Nausea—Timolol—coronary artery disease	4.21e-05	0.000212	CcSEcCtD
Bupivacaine—Vomiting—Lisinopril—coronary artery disease	4.18e-05	0.00021	CcSEcCtD
Bupivacaine—Headache—Lisinopril—coronary artery disease	4.12e-05	0.000207	CcSEcCtD
Bupivacaine—Nausea—Lisinopril—coronary artery disease	3.91e-05	0.000196	CcSEcCtD
Bupivacaine—CYP2C19—Metabolism—VCAN—coronary artery disease	7.79e-06	0.000107	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCND1—coronary artery disease	7.78e-06	0.000107	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—P4HB—coronary artery disease	7.74e-06	0.000107	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALDOA—coronary artery disease	7.73e-06	0.000107	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ARNTL—coronary artery disease	7.72e-06	0.000106	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HADH—coronary artery disease	7.72e-06	0.000106	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	7.6e-06	0.000105	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	7.6e-06	0.000105	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MMP9—coronary artery disease	7.55e-06	0.000104	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—DCN—coronary artery disease	7.5e-06	0.000103	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SULT1E1—coronary artery disease	7.45e-06	0.000103	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	7.41e-06	0.000102	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—AKT1—coronary artery disease	7.33e-06	0.000101	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GPX2—coronary artery disease	7.31e-06	0.000101	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOA2—coronary artery disease	7.31e-06	0.000101	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	7.31e-06	0.000101	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALDH2—coronary artery disease	7.3e-06	0.000101	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SULT1A1—coronary artery disease	7.23e-06	9.95e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HK1—coronary artery disease	7.23e-06	9.95e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ABCG5—coronary artery disease	7.23e-06	9.95e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GPX4—coronary artery disease	7.23e-06	9.95e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	7.22e-06	9.94e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—VCAN—coronary artery disease	7.17e-06	9.87e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HADHA—coronary artery disease	7.14e-06	9.84e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	7.12e-06	9.81e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HBA1—coronary artery disease	7.11e-06	9.8e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—LIPC—coronary artery disease	7.11e-06	9.8e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3C2A—coronary artery disease	7.11e-06	9.8e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALDOA—coronary artery disease	7.11e-06	9.8e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HK2—coronary artery disease	7.11e-06	9.79e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AKR1B1—coronary artery disease	7.11e-06	9.79e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—APOC3—coronary artery disease	7.07e-06	9.74e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTA1—coronary artery disease	7.06e-06	9.72e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—LDLR—coronary artery disease	7.03e-06	9.68e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	7.02e-06	9.67e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—LPA—coronary artery disease	6.98e-06	9.61e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SLC9A1—coronary artery disease	6.94e-06	9.57e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTT1—coronary artery disease	6.94e-06	9.57e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—DCN—coronary artery disease	6.9e-06	9.51e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CETP—coronary artery disease	6.86e-06	9.46e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GCLC—coronary artery disease	6.86e-06	9.46e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SLC27A1—coronary artery disease	6.81e-06	9.39e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SDC1—coronary artery disease	6.79e-06	9.35e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—VEGFA—coronary artery disease	6.78e-06	9.35e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PLCB3—coronary artery disease	6.76e-06	9.31e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALDH2—coronary artery disease	6.71e-06	9.25e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOA5—coronary artery disease	6.69e-06	9.22e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LCAT—coronary artery disease	6.68e-06	9.2e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CPT1B—coronary artery disease	6.68e-06	9.2e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—P4HB—coronary artery disease	6.56e-06	9.04e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOA4—coronary artery disease	6.56e-06	9.03e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—LIPC—coronary artery disease	6.54e-06	9.01e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HBA1—coronary artery disease	6.54e-06	9.01e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	6.54e-06	9.01e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP2C19—coronary artery disease	6.54e-06	9.01e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—APOC3—coronary artery disease	6.5e-06	8.96e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	6.5e-06	8.95e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—LDLR—coronary artery disease	6.46e-06	8.9e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	6.44e-06	8.87e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PSMA6—coronary artery disease	6.41e-06	8.83e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PSMB5—coronary artery disease	6.41e-06	8.83e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	6.4e-06	8.82e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTT1—coronary artery disease	6.39e-06	8.8e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SLC9A1—coronary artery disease	6.39e-06	8.8e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	6.37e-06	8.77e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PDHA1—coronary artery disease	6.33e-06	8.73e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GCLM—coronary artery disease	6.33e-06	8.73e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CETP—coronary artery disease	6.31e-06	8.7e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GCLC—coronary artery disease	6.31e-06	8.7e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	6.29e-06	8.67e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CTGF—coronary artery disease	6.26e-06	8.63e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SDC1—coronary artery disease	6.24e-06	8.6e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TGFB1—coronary artery disease	6.23e-06	8.58e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HMGCR—coronary artery disease	6.21e-06	8.55e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GOT2—coronary artery disease	6.21e-06	8.55e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	6.13e-06	8.45e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	6.13e-06	8.45e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MAPK1—coronary artery disease	6.11e-06	8.41e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—VCAN—coronary artery disease	6.07e-06	8.36e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	6.04e-06	8.32e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALDOA—coronary artery disease	6.02e-06	8.3e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HADH—coronary artery disease	5.95e-06	8.2e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ARNTL—coronary artery disease	5.95e-06	8.2e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PSMA6—coronary artery disease	5.9e-06	8.12e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PSMB5—coronary artery disease	5.9e-06	8.12e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—DCN—coronary artery disease	5.85e-06	8.06e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CTGF—coronary artery disease	5.76e-06	7.94e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HMGCR—coronary artery disease	5.71e-06	7.87e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GOT2—coronary artery disease	5.71e-06	7.87e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PLCB1—coronary artery disease	5.71e-06	7.86e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALDH2—coronary artery disease	5.69e-06	7.84e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	5.65e-06	7.78e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GPX2—coronary artery disease	5.65e-06	7.78e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOA2—coronary artery disease	5.65e-06	7.78e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.6e-06	7.71e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	5.58e-06	7.68e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GPX4—coronary artery disease	5.58e-06	7.68e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HK1—coronary artery disease	5.58e-06	7.68e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ABCG5—coronary artery disease	5.58e-06	7.68e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	5.55e-06	7.64e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HBA1—coronary artery disease	5.54e-06	7.64e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—LIPC—coronary artery disease	5.54e-06	7.64e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP2C19—coronary artery disease	5.54e-06	7.64e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	5.54e-06	7.64e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ABCA1—coronary artery disease	5.53e-06	7.62e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HADHA—coronary artery disease	5.51e-06	7.59e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOC3—coronary artery disease	5.51e-06	7.59e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—LDLR—coronary artery disease	5.48e-06	7.54e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	5.47e-06	7.54e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTA1—coronary artery disease	5.45e-06	7.5e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTT1—coronary artery disease	5.41e-06	7.45e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SLC9A1—coronary artery disease	5.41e-06	7.45e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LPA—coronary artery disease	5.39e-06	7.42e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GGT1—coronary artery disease	5.36e-06	7.38e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GOT1—coronary artery disease	5.36e-06	7.38e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CETP—coronary artery disease	5.35e-06	7.37e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GCLC—coronary artery disease	5.35e-06	7.37e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CA—coronary artery disease	5.3e-06	7.3e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SDC1—coronary artery disease	5.29e-06	7.29e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PLCB1—coronary artery disease	5.25e-06	7.23e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PLCB3—coronary artery disease	5.22e-06	7.19e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOA5—coronary artery disease	5.16e-06	7.11e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ABCA1—coronary artery disease	5.09e-06	7.01e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—P4HB—coronary artery disease	5.06e-06	6.98e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PSMA6—coronary artery disease	5e-06	6.88e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PSMB5—coronary artery disease	5e-06	6.88e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4.99e-06	6.87e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4.97e-06	6.85e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GOT1—coronary artery disease	4.93e-06	6.79e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GGT1—coronary artery disease	4.93e-06	6.79e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CTGF—coronary artery disease	4.88e-06	6.72e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GOT2—coronary artery disease	4.84e-06	6.66e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HMGCR—coronary artery disease	4.84e-06	6.66e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTP1—coronary artery disease	4.81e-06	6.63e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	4.77e-06	6.57e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HMOX1—coronary artery disease	4.75e-06	6.54e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL6—coronary artery disease	4.69e-06	6.46e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—VCAN—coronary artery disease	4.69e-06	6.45e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CAT—coronary artery disease	4.68e-06	6.45e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALDOA—coronary artery disease	4.65e-06	6.4e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—APOB—coronary artery disease	4.55e-06	6.26e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—DCN—coronary artery disease	4.51e-06	6.22e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PLCB1—coronary artery disease	4.45e-06	6.13e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTP1—coronary artery disease	4.43e-06	6.1e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTM1—coronary artery disease	4.42e-06	6.09e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALDH2—coronary artery disease	4.39e-06	6.05e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	4.39e-06	6.04e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HMOX1—coronary artery disease	4.37e-06	6.01e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.36e-06	6.01e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—LPL—coronary artery disease	4.34e-06	5.98e-05	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AKT1—coronary artery disease	4.33e-06	5.96e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ABCA1—coronary artery disease	4.31e-06	5.94e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CAT—coronary artery disease	4.31e-06	5.93e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HBA1—coronary artery disease	4.28e-06	5.89e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LIPC—coronary artery disease	4.28e-06	5.89e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.28e-06	5.89e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.28e-06	5.89e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOC3—coronary artery disease	4.25e-06	5.86e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GPX1—coronary artery disease	4.24e-06	5.84e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LDLR—coronary artery disease	4.23e-06	5.82e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—APOB—coronary artery disease	4.18e-06	5.76e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTT1—coronary artery disease	4.18e-06	5.75e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	4.18e-06	5.75e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GOT1—coronary artery disease	4.18e-06	5.75e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GGT1—coronary artery disease	4.18e-06	5.75e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GCLC—coronary artery disease	4.13e-06	5.69e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CETP—coronary artery disease	4.13e-06	5.69e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CD36—coronary artery disease	4.13e-06	5.68e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SDC1—coronary artery disease	4.08e-06	5.62e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PPP2CA—coronary artery disease	4.07e-06	5.61e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTM1—coronary artery disease	4.07e-06	5.6e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—LPL—coronary artery disease	3.99e-06	5.5e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—MTHFR—coronary artery disease	3.91e-06	5.39e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GPX1—coronary artery disease	3.9e-06	5.37e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.86e-06	5.31e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.86e-06	5.31e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CD36—coronary artery disease	3.79e-06	5.23e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CTGF—coronary artery disease	3.77e-06	5.19e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTP1—coronary artery disease	3.75e-06	5.17e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	3.75e-06	5.16e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.73e-06	5.14e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GOT2—coronary artery disease	3.73e-06	5.14e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	3.72e-06	5.12e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—AGT—coronary artery disease	3.71e-06	5.12e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HMOX1—coronary artery disease	3.7e-06	5.1e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CAT—coronary artery disease	3.65e-06	5.03e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—APOE—coronary artery disease	3.64e-06	5.01e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—APOA1—coronary artery disease	3.6e-06	4.96e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—MTHFR—coronary artery disease	3.6e-06	4.95e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOB—coronary artery disease	3.54e-06	4.88e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTM1—coronary artery disease	3.45e-06	4.75e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.44e-06	4.75e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.43e-06	4.73e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—AGT—coronary artery disease	3.42e-06	4.71e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—LPL—coronary artery disease	3.38e-06	4.66e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—APOE—coronary artery disease	3.35e-06	4.61e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.33e-06	4.58e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—APOA1—coronary artery disease	3.31e-06	4.56e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GPX1—coronary artery disease	3.3e-06	4.55e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GOT1—coronary artery disease	3.22e-06	4.44e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GGT1—coronary artery disease	3.22e-06	4.44e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CD36—coronary artery disease	3.21e-06	4.43e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	3.17e-06	4.37e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PPARG—coronary artery disease	3.17e-06	4.37e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—POMC—coronary artery disease	3.13e-06	4.31e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—MTHFR—coronary artery disease	3.05e-06	4.2e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PPARG—coronary artery disease	2.92e-06	4.02e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.89e-06	3.99e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—AGT—coronary artery disease	2.89e-06	3.99e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—POMC—coronary artery disease	2.88e-06	3.96e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.87e-06	3.95e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.85e-06	3.93e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALB—coronary artery disease	2.85e-06	3.93e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOE—coronary artery disease	2.84e-06	3.91e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CAT—coronary artery disease	2.82e-06	3.88e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOA1—coronary artery disease	2.8e-06	3.86e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOB—coronary artery disease	2.73e-06	3.77e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NOS3—coronary artery disease	2.73e-06	3.76e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.68e-06	3.7e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.66e-06	3.66e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALB—coronary artery disease	2.62e-06	3.61e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LPL—coronary artery disease	2.61e-06	3.6e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GPX1—coronary artery disease	2.55e-06	3.51e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NOS3—coronary artery disease	2.51e-06	3.45e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PTGS2—coronary artery disease	2.49e-06	3.44e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CD36—coronary artery disease	2.48e-06	3.42e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PPARG—coronary artery disease	2.47e-06	3.4e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.45e-06	3.37e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—POMC—coronary artery disease	2.44e-06	3.36e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.35e-06	3.24e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PTGS2—coronary artery disease	2.29e-06	3.16e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AGT—coronary artery disease	2.23e-06	3.08e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALB—coronary artery disease	2.22e-06	3.06e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOE—coronary artery disease	2.19e-06	3.01e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOA1—coronary artery disease	2.16e-06	2.98e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NOS3—coronary artery disease	2.12e-06	2.93e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.94e-06	2.68e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PPARG—coronary artery disease	1.91e-06	2.63e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—POMC—coronary artery disease	1.88e-06	2.59e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALB—coronary artery disease	1.71e-06	2.36e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NOS3—coronary artery disease	1.64e-06	2.26e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CA—coronary artery disease	1.53e-06	2.11e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.5e-06	2.07e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.41e-06	1.94e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—AKT1—coronary artery disease	1.25e-06	1.73e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	1.2e-06	1.65e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—AKT1—coronary artery disease	1.15e-06	1.59e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—AKT1—coronary artery disease	9.77e-07	1.35e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	9.23e-07	1.27e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AKT1—coronary artery disease	7.54e-07	1.04e-05	CbGpPWpGaD
